Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Finally listened to call

<< Previous

Bullboard Posts

Next >>

Comment by Joemareon Oct 14, 2022 12:07pm

87 Views

Post# 35024927

RE:RE:RE:RE:RE:RE:RE:RE:Finally listened to call

You write "Patient accrual is a problem". Do you have any proof of this or are you just making this up like everythig else you write??

Really???

Cough up the numbers to shut me up! I want to be proven wrong all the way.....I'll be a very happy shareholder making money. I want to be proven wrong. Now, I'm loosing money........That's the issue.

<< Previous

Bullboard Posts

Next >>

Ivanhoe Mines initiates Phase 3 concentrator construction